Valuation Genpharmasec Limited
Stocks
ADIRASA
INE861N01036
Medical Equipment, Supplies & Distribution
|
Delayed
Bombay S.E.
03:55:06 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 1.020 INR | 0.00% |
|
-2.86% | -22.14% |
Company Valuation: Genpharmasec Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 2,808 | 2,218 | 1,523 | 861 | 1,235 | 1,009 |
| Change | - | -21.03% | -31.34% | -43.45% | 43.41% | -18.31% |
| Enterprise Value (EV) 1 | 2,760 | 2,074 | 1,463 | 855.3 | 1,056 | 999.3 |
| Change | - | -24.83% | -29.46% | -41.55% | 23.46% | -5.36% |
| P/E | 648x | 173x | -550x | 77.8x | -545x | 94.5x |
| PBR | 14.8x | 10.7x | 9.91x | 5.62x | 1.85x | 1.61x |
| PEG | - | 1x | 5x | -0x | 5x | -0x |
| Capitalization / Revenue | 17x | 10.4x | 5.57x | 3.37x | 4.06x | 2.99x |
| EV / Revenue | 16.7x | 9.74x | 5.36x | 3.35x | 3.47x | 2.96x |
| EV / EBITDA | 422x | 174x | -281x | 319x | 5,126x | -249x |
| EV / EBIT | 426x | 176x | -273x | 344x | 27,075x | -134x |
| EV / FCF | -548x | 282x | -33.1x | -19.6x | -36.2x | -110x |
| FCF Yield | -0.18% | 0.35% | -3.02% | -5.1% | -2.76% | -0.91% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.02 | 0.0464 | -0.01 | 0.04 | -0.004091 | 0.02 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 165 | 213.1 | 273.2 | 255.2 | 304.1 | 337.2 |
| EBITDA 1 | 6.534 | 11.94 | -5.213 | 2.681 | 0.206 | -4.021 |
| EBIT 1 | 6.485 | 11.82 | -5.355 | 2.484 | 0.039 | -7.472 |
| Net income 1 | 10.09 | 12.57 | -2.093 | 11.25 | -1.257 | 12.31 |
| Net Debt 1 | -48.63 | -143.2 | -59.41 | -5.736 | -178.9 | -9.403 |
| Reference price 2 | 12.950 | 8.010 | 5.500 | 3.110 | 2.230 | 1.890 |
| Nbr of stocks (in thousands) | 216,860 | 276,860 | 276,860 | 276,860 | 553,720 | 533,720 |
| Announcement Date | 11/28/20 | 9/6/21 | 9/6/22 | 9/1/23 | 7/1/24 | 9/5/25 |
1INR in Million2INR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 5.91M | |
| 31.91x | 4.3x | 16.65x | 2.31% | 193B | |
| 20.68x | 3.58x | 12.58x | 3.26% | 117B | |
| 17.18x | 0.2x | 12.43x | 0.76% | 59.89B | |
| 32.51x | 8.12x | 20.71x | 1.22% | 56.01B | |
| 35.34x | 3.41x | 11.7x | 2.14% | 49.96B | |
| 35.98x | 6.33x | 19.87x | -.--% | 33.87B | |
| 46.51x | 1.32x | 12.08x | 0.16% | 31.36B | |
| 20.88x | 3.19x | 11.7x | 1.4% | 24.77B | |
| 40.75x | 7.14x | 25.62x | 0.26% | 24.59B | |
| Average | 31.30x | 4.18x | 15.93x | 1.28% | 58.98B | |
| Weighted average by Cap. | 29.45x | 4.06x | 15.49x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ADIRASA Stock
- Valuation Genpharmasec Limited
Select your edition
All financial news and data tailored to specific country editions
